AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 163 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,934,000 | +0.7% | 85,336 | -12.6% | 0.00% | 0.0% |
| Q3 2014 | $2,915,000 | +400.9% | 97,651 | +236.5% | 0.00% | +200.0% |
| Q2 2014 | $582,000 | -35.7% | 29,018 | -12.8% | 0.00% | 0.0% |
| Q1 2014 | $905,000 | +36.7% | 33,290 | +4.2% | 0.00% | 0.0% |
| Q4 2013 | $662,000 | -69.6% | 31,951 | -73.3% | 0.00% | -50.0% |
| Q3 2013 | $2,179,000 | +9.2% | 119,745 | -0.2% | 0.00% | 0.0% |
| Q2 2013 | $1,995,000 | – | 119,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |